George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cost reductions;delay to Ann. Report;New contract

5 Jun 2023 07:00

RNS Number : 5720B
Deepverge PLC
05 June 2023
 

5 June 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company" or "the Group")

 

Further cost reductions; Possible delay to publication of Annual Report and Accounts; New £2.3m, four-year contract

 

DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces that: (i) it will be downsizing its Labskin, Skin Trust Club and Rinocloud business units as part of further measures to improve the financial position of the Group; (ii) it is possible that it will need to delay the announcement of its results for the year ended 31 December 2022 and publication of its Annual Report and Accounts for the same period; (iii) it is continuing to carefully manage its working capital position and to seek new financing opportunities and also consider the potential sale of one or more lines of its business; and (iv) it is pleased to announce a new manufacturing contract win. 

Downsizing of the Labskin, Skin Trust Club and Rinocloud business units

The Company's financial position is such that the Board has taken the decision to no longer support the ongoing costs of progressing the development of the Labskin, Skin Trust Club and associated elements of the Rinocloud businesses, whilst retaining the capacity required to continue supporting the Modern Water and Glanaco businesses. The Company is therefore downsizing these business units, with effect from 1 July 2023, which will involve the elimination of approximately twenty permanent employee and contract positions. A programme is now in progress to ensure an orderly downsizing process is conducted.  The Company remains proud of the patents and databases that have been developed to date and continues to explore out-licensing opportunities of this technology with companies engaged in the life-sciences industry.

Possibility of delay to the announcement of the results for the year ended 31 December 2022 and publication of the Annual Report

The possibility of delay is caused, inter alia, by the resignation of the Group's previous auditor, Jeffreys Henry LLP, as announced on 24 March 2023. Following a change of ownership and name, Jeffreys Henry LLP undertook a review of its capacity to undertake audit work, in conjunction with the Institute of Chartered Accountants in England and Wales which concluded that the firm did not have sufficient capacity to satisfy its regulatory requirements and as a result resigned as auditor to a number of quoted companies, including DeepVerge.

 

The resignation of Jeffreys Henry occurred just days before the audit of DeepVerge's accounts was due to start. Haysmacintyre LLP was subsequently appointed as the Company's auditor, however there is significant risk of there being insufficient time to ensure that the audit is completed by 30 June 2023.

If the Company is unable to publish its Annual Report and Accounts by 30 June 2023 in accordance with AIM Rule 19, then the trading in the Company's ordinary shares on AIM would be suspended from 7.30am on Monday 3 July 2023 until such Annual Report is published. Any such delay would be likely to be limited to a matter of weeks.

New Funding opportunities and potential sale of parts of the business

The Company announced (RNSs of 17 and 19 April 2023) that due to the phasing and timing of contract cashflows it was operating from a limited working capital position. The Company continues to explore a number of financing options including the raising of equity, debt or trade finance to improve the Group's financial position. The Company is also exploring the potential sale of one or more lines of business.

New Manufacturing Contract in Ireland

The Company is pleased to announce that its subsidiary, Glanaco Ltd., has won a new contract for the supply of customised environmental cleaning and monitoring equipment to an undisclosed customer within the EU. Under the terms of the deal the Company will lease this equipment to the customer across a four-year period commencing in the second half of 2023.

The overall revenue will amount to approximately £2.3 million and will be recognised across the coming four years.

Further updates will be given as appropriate.

 

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSLFLLEDSEDM
Date   Source Headline
27th Dec 20237:00 amRNSCancellation - DEEPVERGE PLC
20th Dec 202312:30 pmRNSUpdate; exclusivity agreement with Microsaic
13th Dec 20234:38 pmRNSUpdate
14th Sep 20237:00 amRNSNew Website, Update
7th Aug 20232:30 pmRNSDisposal;Update; Related Party Trans'n-replacement
7th Aug 20237:00 amRNSDisposal; Update
2nd Aug 20239:35 amRNSBoard Change
1st Aug 20237:00 amRNSCompany Secretary Change
12th Jul 20237:00 amRNSUpdate
5th Jul 202311:26 amRNSUpdate
26th Jun 20237:30 amRNSSuspension - Deepverge PLC
26th Jun 20237:00 amRNSSale or closure of subsidiaries; share suspension
5th Jun 20237:00 amRNSCost reductions;delay to Ann. Report;New contract
19th Apr 20231:21 pmRNSMicrosaic Creditor; Update
17th Apr 20237:00 amRNS2022 revenue update - revision
24th Mar 202310:24 amRNSChange of Auditor
6th Mar 20234:35 pmRNSPrice Monitoring Extension
6th Mar 20232:05 pmRNSSecond Price Monitoring Extn
6th Mar 20232:00 pmRNSPrice Monitoring Extension
22nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
22nd Feb 20234:35 pmRNSPrice Monitoring Extension
7th Feb 20237:00 amRNSBoard Appointment
6th Feb 20235:30 pmRNSSignificant contract win and Board change
2nd Feb 20234:40 pmRNSSecond Price Monitoring Extn
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
9th Jan 20237:00 amRNS2022 Revenue Update
23rd Nov 20224:10 pmRNSTR-1: Notification of major holdings
22nd Nov 20227:00 amRNSAccelerated Restructuring
16th Nov 20229:00 amRNSDirector/PDMR Shareholding
14th Nov 202212:16 pmRNSResult of Meeting
11th Nov 20224:37 pmRNSHolding(s) in Company
7th Nov 20227:00 amRNSDirectorate and Management Changes
3rd Nov 202212:32 pmRNSDirectorate Change
1st Nov 20223:56 pmRNSResult of Broker Offer; Total Voting Rights
31st Oct 20222:23 pmRNSBroker Offer to raise a max of £2.5m - replacement
31st Oct 20222:18 pmRNSExtension of Broker Offer to 430pm on 31 October
28th Oct 20221:06 pmRNSExtension of Broker Offer
27th Oct 20227:01 amRNSBroker Offer to raise a maximum of £2.5m
27th Oct 20227:00 amRNS£10m Placing, Broker Option, RPTs, Notice of GM
25th Oct 20222:05 pmRNSSecond Price Monitoring Extn
25th Oct 20222:00 pmRNSPrice Monitoring Extension
25th Oct 20227:01 amRNSUpdate - Proposed Financing,Proposed Board Changes
25th Oct 20227:00 amRNSHistorical Related Party Transactions
12th Oct 20224:41 pmRNSSecond Price Monitoring Extn
12th Oct 20224:35 pmRNSPrice Monitoring Extension
12th Oct 20227:04 amRNSResponse to Market Speculation
11th Oct 202211:05 amRNSSecond Price Monitoring Extn
11th Oct 202211:00 amRNSPrice Monitoring Extension
4th Oct 20227:00 amRNSLabskin contract
30th Sep 20224:41 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.